Primary biliary cirrhosis: symptomatic treatment.
Elias
E
E
Liver Unit, Queen Elizabeth Hospital, Birmingham, UK.
Burra
P
P
D000328:Adult; D001361:Avitaminosis / Q000188:drug therapy / Q000209:etiology; D002792:Cholestyramine Resin / Q000627:therapeutic use; D005260:Female; D006633:Histamine Antagonists / Q000627:therapeutic use; D006801:Humans; D006975:Hypertension, Portal / Q000209:etiology; D008105:Liver Cirrhosis, Biliary / Q000150:complications / Q000628:therapy*; D009270:Naloxone / Q000627:therapeutic use; D010024:Osteoporosis / Q000188:drug therapy / Q000209:etiology; D011537:Pruritus / Q000188:drug therapy; D014580:Ursodeoxycholic Acid / Q000627:therapeutic use
D006633:Histamine Antagonists; D002792:Cholestyramine Resin; D009270:Naloxone; D014580:Ursodeoxycholic Acid